Cancer Biotherapy and Radiopharmaceuticals

FREE ACCESS through December 27, 2016.
Read Now:

Peptide Receptor Radionuclide Therapy: An Overview 
Ashutosh Dash, Sudipta Chakraborty, Maroor Raghavan Ambikalmajan Pillai, and Furn F. (Russ) Knapp Jr.  Read Now

Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis 
Zeynep Gozde Ozkan, Arzu Poyanli, Adem Ucar, Serkan Kuyumcu, Filiz Akyuz, Serkan Keskin, Sezer Saglam, Ebru Yilmaz, Cetin Karaca, and Cuneyt Turkmen  Read Now

First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with ⁶⁸Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for α_vβ₃ Integrin Receptor Targeting 
Richard P. Baum, Harshad R. Kulkarni, Dirk Müller, Stanley Satz, Narasimhan Danthi, Young-Seung Kim, and Martin W. Brechbiel  Read Now

One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer 
Hossein Jadvar, Sudha Challa, David I. Quinn, and Peter S. Conti  Read Now

NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study 
Phillip G. Claringbold and J. Harvey Turner  Read Now

TRPM2 Mediates Histone Deacetylase Inhibition-Induced Apoptosis in Bladder Cancer Cells 
Qi-feng Cao, Su-bo Qian, Ning Wang, Liang Zhang, Wei-ming Wang, and Hai-bo Shen  Read Now

READ MORE FROM THE JOURNAL

EMAIL TO A COLLEAGUE

Alexandros Sfakianakis
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182

6948891480

alsfakia@gmail.com